medigraphic.com
ISSN 1560-4381 (Print)

2021, Number 4

<< Back Next >>

Correo Científico Médico 2021; 25 (4)

Prognostic assessment of death due to cardiorenal syndrome in patients with acute myocardial infarction

Pérez DJA, Ortega VYR, Batista CL, Rodríguez PMM, Pérez OA

Language: Spanish
References: 34
Page:
PDF size: 721.74 Kb.


ABSTRACT

Introduction: Cardiorenal syndrome represents the worsening of the renal function in patients with acute myocardial infarction and is considered an independent risk factor of increased mortality.
Objective: To identify the prognostic factors of death in infarcted patients with cardiorenal syndrome.
Methods: An analytical study of cases and witnesses was made with 123 patients diagnosed with cardiorenal syndrome due to acute myocardial infarction, admitted in the Coronary Intensive Care Unit of Carlos Manuel de Céspedes General Teaching Hospital, Granma, Cuba, from January 12, 2017 to July 12, 2020. Odds Ratio (OR) and its 95% confidence intervals (95%CI) of the factors in simple and multiple logistic regression were calculated in SPSS 24 for Windows.
Results: The prevalence of cardiorenal syndrome was 37.2% with mean age 62.4 (12.8) years. Sample mortality due to cardiorenal syndrome was 33.3% (41 patients out of 123). Predictor independent variables of death due to cardiorenal syndrome were metabolic syndrome (OR = 3.8; 95%IC = 1.2- 12), left ventricular dysfunction (OR = 2.6; 95%IC = 1.2- 5.1) and glomerular filtration rate < 74 ml/min/1.73 m2 (OR = 2; 95%IC = 1.1-9.6).
Conclusions: Death risk increased from 2 to 3 times in infarcted patients with cardiorenal syndrome that presented metabolic syndrome, left ventricular dysfunction and reduced glomerular filtration rate.
The factors obtained using the logistic regression model constitute an useful tool to assess the influence of cardiorenal syndrome on mortality due to acute myocardial infarction.


REFERENCES

  1. Núñez J, Miñana G, Santas E, Bertomeu González V. Síndrome cardiorrenal en la insuficiencia cardiaca aguda: revisando paradigmas. Rev Española Cardiol. 2015[citado 15/08/2021];68(5): 426-435. Disponible en: https://www.revespcardiol.org/es-sindrome-cardiorrenal-insuficiencia-cardiaca-aguda-articulo-S0300893215000123

  2. Ronco C, Peter McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM,et al. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J. 2010[citado 15/08/2021]; 31(6): 703-711. Disponible en: https://academic.oup.com/eurheartj/article/31/6/703/419179

  3. Zannad F, Rossignol P. Cardiorenal Syndrome Revisited. Circulation. 2018[citado 15/08/2021]; 138(9):929-944.Disponible en: https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.117.028814

  4. Salleck D, John S. Das kardiorenale Syndrom. Wien klin Mag. 2019[citado 15/08/2021]; 22: 166–170. Disponible en: https://www.springer.com/journal/740/

  5. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, et al. Renal Impairment and Outcomes in Heart Failure: Systematic Review and Meta-Analysis. J Am Coll Cardiol 2006[citado 25/09/2021];47(10):1987–1996.Disponible en: https://www.jacc.org/doi/abs/10.1016/j.jacc.2005.11.084

  6. Di Lullo L, Reeves PB, Bellasi A, Ronco C. Cardiorenal Syndrome in Acute Kidney Injury. Semin Nephrol. 2019[citado 25/08/2020];39(1):31-40.Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0270929518301542

  7. Rodríguez Jiménez AE, Negrín Valdés T, Cruz Inerarity H, Machural de la Torre PJ. Síndrome cardiorrenal como predictor de mortalidad intrahospitalaria en el síndrome coronario agudo con elevación del segmento ST. Clín e Investig Arteriosclerosis. 2018[citado 15/08/2021];30(4):163-169. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0214916818300056?via%3Dihub

  8. Montero Pérez Barquero M, Morales Rull JL. Posibilidades de órgano protección en la insuficiencia cardiaca aguda. Rev Clín Esp(Barc). 2016[citado 25/07/2020];216(3): 157-164.Disponible en: https://www.revclinesp.es/es-posibilidades-organoproteccion-insuficiencia-cardiaca-aguda-articulo-S0014256516000060

  9. Manzur Barbur MC, Mejía-Sanjuanelo AM, Anaya-Taboada M, García-Domínguez JC, Molano- Triviño A. Estado del arte del síndrome cardiorrenal, ventajas y limitaciones de las terapias conocidas. Rev Colomb Nefrol. 2021 [citado 04/10/2021];8(2):e517. Disponible en: https://revistanefrologia.org/index.php/rcn/article/view/517

  10. Llauger LL, Jacob J, Miró O. Función renal y pronóstico de los episodios de insuficiencia cardíaca aguda. Med Clín(Barc). 2018[citado 25/08/2020];151(7): 281-290.Disponible en: https://www.elsevier.es/en-revista-medicina-clinica-2-articulo-funcion-renal-pronostico-los-episodios-S0025775318303099

  11. Cuevas Campillo A. Factores de riesgo para la presentación del síndrome cardiorrenal tipo I en pacientes con diagnóstico de insuficiencia cardiaca crónica descompensada en el servicio de medicina interna del hospital general de atizapan en el periodo de marzo 2013 a octubre 2016. [Tesis].[Toluca, Estado de México]: Hospital General de Atizapan “Dr. Salvador González Herrejón”;2017.93 p. Disponible en: http://ri.uaemex.mx/bitstream/handle/20.500.11799/65485/8%20Tesis%20Axel%20Cuevas%20Campillo%20Cuenta%20MEDICINA%20INTE..pdf?sequence=1&isAllowed=y

  12. Thind G, Loehrke M, Wilt J. Acute cardiorenal syndrome: Mechanisms and clinical implications. Cleve Clin J Med. 2018[citado 15/08/2020];85(3):231-239.Disponible en: https://www.ccjm.org/content/85/3/231

  13. Cockcroft DW, Gault MH. Prediction of creatine clearance from serum creatinine. Nephron 1976[citado 28/07/2020]; 16(1): 31-41.Disponible en: https://www.karger.com/Article/Abstract/180580

  14. Levey A, Stevens L, Schmid CH, Lucy Zhang Y, Castro A, Feldman H, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2011 [citado 25/08/2020];150(9):604-612.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763564

  15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001[citado 280/08/2020];285(19):2486-2497.Disponible en: https://jamanetwork.com/journals/jama/article-abstract/193847

  16. Jacobson T, Ito M , Maki K, Orringer C ,Bays H,Jones P, et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report. J Clin Lipidol. 2015[citado 27/01/2021];9(2):129-169:Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1933287415000598

  17. Thierer J. Síndrome cardiorrenal. Una revisión. Rev Urug Cardiol. 2018 [citado 29/04/2021]; 33(1): 90-109. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-04202018000100081

  18. De Melo Leite A, Ferraz de Oliveira Gomes B, Casarsa Marques A, Fernandes Petriz JL, Campos de Albuquerque D, Pimenta de Mello Spineti P, et al. Acute Cardiorenal Syndrome: Which Diagnostic Criterion to Use And What is its Importance for Prognosis?. Arq Bras Cardiol. 2020[citado 25/01/2020];115(1): 127-133.Disponible en: http://publicacoes.cardiol.br/portal/abc/ingles/2020/v11501/pdf/i11501022.pdf

  19. Avila Rodriguez LV, Montero O, Toro J, Mondragon Cardona Á, Jiménez Canizales CE. Prevalencia de síndrome cardiorrenal en un hospital de referencia del suroriente colombiano, 2013-2015. Acta Méd Colomb. 2016[citado 25/08/2021];41 (3 Supl 1): 95. Disponible en: https://go.gale.com/ps/anonymous?id=GALE%7CA472372538&sid=googleScholar&v=2.1&it=r&linkaccess=abs&issn=01202448&p=IFME&sw=w

  20. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, et al. Prevalence of kidney damage in Australian adults: The AusDiab Kidney Study. J Am Soc Nephrol. 2003[citado 24/06/2021];14(7 Suppl 2): 131-138.Disponible en: https://jasn.asnjournals.org/content/14/suppl_2/S131

  21. Rubinstein J, Sanford D. Treatment of Cardiorenal Syndrome. Cardiol Clin. 2019[citado 25/08/2021];37(3):267-273.Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0733865119300281?via%3Dihub

  22. Tabucanon T, Wilson Tang WH. Right Heart Failure and Cardiorenal Syndrome. Cardiol Clin. 202[citado 25/05/2021];38(2):185-202.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160202/

  23. Ronco C, Bellasi A, Di Lullo L. Cardiorenal Syndrome: An Overview. Adv Chronic Kidney Dis. 2018[citado 15/07/2020];25(5):382-390.Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1548559518301204

  24. Costanzo MR. The Cardiorenal Syndrome in Heart Failure. Heart Fail Clin. 2020[citado 15/08/2021];16(1):81-97.Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1551713619300947?via%3Dihub

  25. Di Lullo L, Bellasi A, Barbera V, Russo D, Russo L, Di Iorio B, et al. Pathophysiology of the cardio-renal syndromes types 1–5: An uptodate. Indian Heart J. 2017 [citado 29/04/2021]; 69(2): 255-265. Disponible en: https://www.sciencedirect.com/science/article/pii/S0019483216304072?via%3Dihub

  26. Khan NA,Ma I, Thompson CR, Humphries K,Salem D, Sarnak M, et al. Kidney function and mortality among patients with left ventricular systolic dysfunction. J Am Soc Nephrol. 2006[citado 25/08/2020];17(1):244-253.Disponible en: https://jasn.asnjournals.org/content/17/1/244.short

  27. Huaman Mejía YD. Injuria renal aguda como factor asociado a mortalidad en pacientes con síndrome isquémico coronario agudo del servicio de medicina especialidades del Hospital III José Cayetano Heredia ESSALUD Piura. 2014-2017[Tesis].[ Piura,Peru]:Universidad Privada Antenor Orrego; 2018. 47p.Disponible en: https://repositorio.upao.edu.pe/bitstream/20.500.12759/4028/1/REP_MED.HUMA_YENIFFER.HUAMAN_INJURIA.RENAL.AGUDA.FACTOR.ASOCIADO.MORTALIDAD.PACIENTES.S%c3%8dNDROME.ISQU%c3%89MICO.CORONARIO.AGUDO.SERIVICIO.MEDICINA.ESPECIALIDADES.HOSPITAL.III.JOS%c3%89.CAYETANO.HEREDIA.ESSALUD.PIURA.2014.2017.pdf

  28. Yancy C, Lopatin M, Warner Stevenson L, De Marco T, Fonarow G, ADHERE Scientific Advisory Committee and Investigators. Clinical Presentation, Management, and In-Hospital Outcomes of Patients Admitted With Acute Decompensated Heart Failure With Preserved Systolic Function A Report From the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006[citado 25/04/2020];47(1):76-84.Disponible en: https://www.jacc.org/doi/full/10.1016/j.jacc.2005.09.022

  29. Raina R, Nair N, Chakraborty R, Nemer L, Dasgupta R, Varian K. An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome. Cardiol Res. 2020[citado 28/05/2020]; 11(2):76-88.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092771

  30. Madeira M, Caetano F, Almeida I, Fernández A, Reis L, Costa M, et al. Inotropes and cardiorenal syndrome in acute heart failure. A retrospective comparative analysis. Rev Port Cardiol. 2017[citado 15/07/2020];36(9):619-625.Disponible en: https://www.sciencedirect.com/science/article/pii/S2174204917302404

  31. Meza Ayala CM, Dehesa López EE. Factores asociados con lesión renal aguda en pacientes hospitalizados con diagnóstico de insuficiencia cardíaca agudizada. Med Interna Méx.2018[citado 28/07/2020];34(1):19-28.Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0186-48662018000100004

  32. Bono J, Perna ER, Macín Stella M. Fallo renal e infarto de miocardio ¿un marcador pronóstico? Registro argentino de infarto agudo de miocardio SAC-FAC. Rev Fed Arg Cardiol. 2018[citado 15/08/2021]; 47(2):91-96. Disponible en:https://docplayer.es/116154502-Fallo-renal-e-infarto-agudo-de-miocardio-un-marcador-pronostico-registro-argentino-de-infarto-agudo-de-miocardio-sac-fac.html

  33. Hoste EA, Clermontb G, Kersten A. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill Patients: A cohort Analysis. Crit Care.2006[citado 28/05/2020];10(3).Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550961/

  34. Rangaswami J, Mathew RO. Pathophysiological Mechanisms in Cardiorenal Syndrome. Adv Chronic Kidney Dis. 2018[citado 28/05/2020];25(5):400-407.Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S154855951830140X




2020     |     www.medigraphic.com